(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRISTOL PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

PRISTOL PHARMACEUTICALS

ST13

US500000090636702

Class

35

Filing

90636702

Registration

6750631

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

06/07/2022

Classification

Registered

Trademark type

Combined

Nice classes

35

Filing date

04/10/2021

Registration date

06/07/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/07/2022

Last transaction

06/07/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

11/27/2019

First use in commerce

11/27/2019

Drawing code

3

Owner type

16

Owner location

Las Vegas, NV

Examiner

PRIZANT, JAMES

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "Pristol Pharmaceuticals" where the "P" letter of Pristol is surrounded by three triangles (up, left, down ). The word "Pristol" appears in dark blue letters above the word "Pharmaceuticals" in dark blue initial capital lettering. On the left of the wording, the "P" letter is surrounded by three triangles, the upper triangle is red-colored where the left big triangle is yellow-colored and the down triangle is green-colored. The white is not claimed as a feature of the mark and represents background or transparent areas.

Holders and representatives

Holders

Pristol Pharmaceuticals Ltd

Representatives

Pristol Pharmaceuticals Ltd

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Marketing the pharmaceutical preparations of others for the treatment of osteoarthritissexual dysfunctionpain and inflammationkidney stonesGI hyperaciditygastrointestinal diseaseelevated uric acid by distributing couponsproviding hyperlinks to websites of others; On-line trading services in which users post requests for pharmaceutical preparationsfor the treatment of osteoarthritissexual dysfunctionpain and inflammationkidney stonesGI hyperaciditygastrointestinal diseaseelevated uric acidnegotiate transactions for them via the Internet

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/07/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

06/07/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/22/2022

PUBO

PUBLISHED FOR OPPOSITION

03/22/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/17/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/26/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/26/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/26/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/05/2022

GNRT

NON-FINAL ACTION E-MAILED

01/05/2022

CNRT

NON-FINAL ACTION WRITTEN

01/05/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/29/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/29/2021

ALIE

ASSIGNED TO LIE

12/29/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/26/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/07/2021

GNRT

NON-FINAL ACTION E-MAILED

12/07/2021

CNRT

NON-FINAL ACTION WRITTEN

12/07/2021

DOCK

ASSIGNED TO EXAMINER

11/30/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/20/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/18/2021

NWAP

NEW APPLICATION ENTERED

04/14/2021

Continuous trademark protection

Get notified about every new filing that threatens PRISTOL PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.